Register today for a LIVE national broadcast on New Treatment Options for Rare Diseases in the Soft Tissue for March 5th and 6th!

News >

Expert Reviews Data for Abemaciclib in Breast Cancer

Published: Monday, Nov 26, 2018

Peter A. Kaufman, MD

Peter A. Kaufman, MD
The treatment options for women with hormone receptor (HR)–positive metastatic breast cancer have evolved rapidly in the past decade, with the introduction of the CDK4 and CDK6 inhibitors representing a major advance, according to Peter Kaufman, MD, during a lunch symposium at the 36th Annual CFS®.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication